Revised prices of 1,364 anti-cancer medicine formulations come into effect

<img src="https://img-cdn.publive.online/fit-in/1280x960/greater-kashmir/media/media_files/2026/05/13/medicine_drugs_ai-2026-05-13-05-50-07.jpg" /><p><span>Srinagar, Nov 9: Revised maximum retail prices (MRPs) of 1,364 anti-cancer medicine formulations came into effect across the country on Monday, with consumers expected to save Rs 3,540.38 crore annually, the Union Ministry of Chemicals and Fertilizers said.</span></p> <p><span>According to a press release issued by the Press Information Bureau (PIB), the National Pharmaceutical Pricing Authority (NPPA) has capped trade margins on the MRPs of 137 anti-cancer drugs based on recommendations of an Expert Committee constituted by the Directorate General of Health Services (DGHS) on October 17, 2026.</span></p> <p><span>As of November 8, a total of 85 pharmaceutical companies had reported revised MRPs for 1,364 anti-cancer formulations covering 121 drugs.</span></p> <p><span>Of these, 679 brands reported price reductions of more than 50 per cent, while the highest reported reduction in MRP stood at 96.45 per cent, the ministry said.</span></p> <p><span>The NPPA, which functions under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has introduced the revised prices as part of the measures to make cancer treatment more affordable.</span></p> <p><span>Consumers can check the revised MRP printed on medicine packs and verify prices through the Pharma Sahi Daam mobile application or the NPPA website.</span></p> <p><span>The ministry said chemists and hospital pharmacies cannot charge more than the revised MRP.</span></p> <p><span>Consumers can register complaints regarding overcharging or other pricing-related issues through the Pharma Jan Samadhan portal or contact the NPPA helpline at 1800-111-255.</span></p>